Hepatocyte growth factor and the risk of ischemic stroke developing among postmenopausal women: Results from the women's health initiative

Swapnil N. Rajpathak, Tao Wang, Sylvia Wassertheil-Smoller, Howard Strickler, Robert C. Kaplan, Aileen P. McGinn, Rachel P. Wildman, Daniel Rosenbaum, Thomas E. Rohan, Philipp E. Scherer, Mary Cushman, Gloria Y F Ho

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

BACKGROUND AND PURPOSE-: Hepatocyte growth factor (HGF) is a potent angiogenic factor and may play a role in the development and progression of atherosclerotic lesions, the underlying mechanism of cardiovascular disease. However, there have been no prospective studies examining the relationship between HGF levels and risk of stroke. METHODS-: We conducted a nested case-control study (972 incident stroke cases and 1:1 age-matched and race-matched controls) to prospectively evaluate the association between plasma HGF and risk of ischemic stroke within the WomenÊ's Health Initiative Observational Study, a cohort of postmenopausal women aged 50 to 79 years. RESULTS-: Baseline HGF levels were correlated positively with body mass index, systolic blood pressure, low-density lipoprotein cholesterol, insulin resistance, and inflammatory markers, such as C-reactive protein, and inversely with high-density lipoprotein cholesterol (all P<0.05). Baseline HGF levels were higher among cases than controls (geometric means, 601.8 vs 523.2 pg/mL; P=0.003). Furthermore, the risk of incident ischemic stroke was significantly greater among women in the highest vs lowest quartile of plasma HGF levels (OR, 1.46; 95% CI, 1.12-1.91; Ptrend=0.003) in a conditional logistic regression model that adjusted for body mass index. These results were only slightly attenuated after further adjustment for additional stroke risk factors (OR, 1.39; 95% CI, 1.04-1.85; Ptrend=0.023). CONCLUSIONS-: Circulating levels of HGF are associated with an increased risk of incident ischemic stroke, independent of obesity and other risk factors for cardiovascular disease, among postmenopausal women aged 50 to 79 years.

Original languageEnglish (US)
Pages (from-to)857-862
Number of pages6
JournalStroke
Volume41
Issue number5
DOIs
StatePublished - May 2010

Fingerprint

Hepatocyte Growth Factor
Women's Health
Stroke
Body Mass Index
Cardiovascular Diseases
Logistic Models
Blood Pressure
Angiogenesis Inducing Agents
C-Reactive Protein
LDL Cholesterol
HDL Cholesterol
Observational Studies
Insulin Resistance
Case-Control Studies
Obesity
Prospective Studies

Keywords

  • Hepatocyte growth factor
  • Ischemic stroke
  • Women

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Clinical Neurology
  • Advanced and Specialized Nursing

Cite this

Hepatocyte growth factor and the risk of ischemic stroke developing among postmenopausal women : Results from the women's health initiative. / Rajpathak, Swapnil N.; Wang, Tao; Wassertheil-Smoller, Sylvia; Strickler, Howard; Kaplan, Robert C.; McGinn, Aileen P.; Wildman, Rachel P.; Rosenbaum, Daniel; Rohan, Thomas E.; Scherer, Philipp E.; Cushman, Mary; Ho, Gloria Y F.

In: Stroke, Vol. 41, No. 5, 05.2010, p. 857-862.

Research output: Contribution to journalArticle

Rajpathak, Swapnil N. ; Wang, Tao ; Wassertheil-Smoller, Sylvia ; Strickler, Howard ; Kaplan, Robert C. ; McGinn, Aileen P. ; Wildman, Rachel P. ; Rosenbaum, Daniel ; Rohan, Thomas E. ; Scherer, Philipp E. ; Cushman, Mary ; Ho, Gloria Y F. / Hepatocyte growth factor and the risk of ischemic stroke developing among postmenopausal women : Results from the women's health initiative. In: Stroke. 2010 ; Vol. 41, No. 5. pp. 857-862.
@article{78919917308d4288ad903a141899a55c,
title = "Hepatocyte growth factor and the risk of ischemic stroke developing among postmenopausal women: Results from the women's health initiative",
abstract = "BACKGROUND AND PURPOSE-: Hepatocyte growth factor (HGF) is a potent angiogenic factor and may play a role in the development and progression of atherosclerotic lesions, the underlying mechanism of cardiovascular disease. However, there have been no prospective studies examining the relationship between HGF levels and risk of stroke. METHODS-: We conducted a nested case-control study (972 incident stroke cases and 1:1 age-matched and race-matched controls) to prospectively evaluate the association between plasma HGF and risk of ischemic stroke within the Women{\^E}'s Health Initiative Observational Study, a cohort of postmenopausal women aged 50 to 79 years. RESULTS-: Baseline HGF levels were correlated positively with body mass index, systolic blood pressure, low-density lipoprotein cholesterol, insulin resistance, and inflammatory markers, such as C-reactive protein, and inversely with high-density lipoprotein cholesterol (all P<0.05). Baseline HGF levels were higher among cases than controls (geometric means, 601.8 vs 523.2 pg/mL; P=0.003). Furthermore, the risk of incident ischemic stroke was significantly greater among women in the highest vs lowest quartile of plasma HGF levels (OR, 1.46; 95{\%} CI, 1.12-1.91; Ptrend=0.003) in a conditional logistic regression model that adjusted for body mass index. These results were only slightly attenuated after further adjustment for additional stroke risk factors (OR, 1.39; 95{\%} CI, 1.04-1.85; Ptrend=0.023). CONCLUSIONS-: Circulating levels of HGF are associated with an increased risk of incident ischemic stroke, independent of obesity and other risk factors for cardiovascular disease, among postmenopausal women aged 50 to 79 years.",
keywords = "Hepatocyte growth factor, Ischemic stroke, Women",
author = "Rajpathak, {Swapnil N.} and Tao Wang and Sylvia Wassertheil-Smoller and Howard Strickler and Kaplan, {Robert C.} and McGinn, {Aileen P.} and Wildman, {Rachel P.} and Daniel Rosenbaum and Rohan, {Thomas E.} and Scherer, {Philipp E.} and Mary Cushman and Ho, {Gloria Y F}",
year = "2010",
month = "5",
doi = "10.1161/STROKEAHA.109.567719",
language = "English (US)",
volume = "41",
pages = "857--862",
journal = "Stroke",
issn = "0039-2499",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Hepatocyte growth factor and the risk of ischemic stroke developing among postmenopausal women

T2 - Results from the women's health initiative

AU - Rajpathak, Swapnil N.

AU - Wang, Tao

AU - Wassertheil-Smoller, Sylvia

AU - Strickler, Howard

AU - Kaplan, Robert C.

AU - McGinn, Aileen P.

AU - Wildman, Rachel P.

AU - Rosenbaum, Daniel

AU - Rohan, Thomas E.

AU - Scherer, Philipp E.

AU - Cushman, Mary

AU - Ho, Gloria Y F

PY - 2010/5

Y1 - 2010/5

N2 - BACKGROUND AND PURPOSE-: Hepatocyte growth factor (HGF) is a potent angiogenic factor and may play a role in the development and progression of atherosclerotic lesions, the underlying mechanism of cardiovascular disease. However, there have been no prospective studies examining the relationship between HGF levels and risk of stroke. METHODS-: We conducted a nested case-control study (972 incident stroke cases and 1:1 age-matched and race-matched controls) to prospectively evaluate the association between plasma HGF and risk of ischemic stroke within the WomenÊ's Health Initiative Observational Study, a cohort of postmenopausal women aged 50 to 79 years. RESULTS-: Baseline HGF levels were correlated positively with body mass index, systolic blood pressure, low-density lipoprotein cholesterol, insulin resistance, and inflammatory markers, such as C-reactive protein, and inversely with high-density lipoprotein cholesterol (all P<0.05). Baseline HGF levels were higher among cases than controls (geometric means, 601.8 vs 523.2 pg/mL; P=0.003). Furthermore, the risk of incident ischemic stroke was significantly greater among women in the highest vs lowest quartile of plasma HGF levels (OR, 1.46; 95% CI, 1.12-1.91; Ptrend=0.003) in a conditional logistic regression model that adjusted for body mass index. These results were only slightly attenuated after further adjustment for additional stroke risk factors (OR, 1.39; 95% CI, 1.04-1.85; Ptrend=0.023). CONCLUSIONS-: Circulating levels of HGF are associated with an increased risk of incident ischemic stroke, independent of obesity and other risk factors for cardiovascular disease, among postmenopausal women aged 50 to 79 years.

AB - BACKGROUND AND PURPOSE-: Hepatocyte growth factor (HGF) is a potent angiogenic factor and may play a role in the development and progression of atherosclerotic lesions, the underlying mechanism of cardiovascular disease. However, there have been no prospective studies examining the relationship between HGF levels and risk of stroke. METHODS-: We conducted a nested case-control study (972 incident stroke cases and 1:1 age-matched and race-matched controls) to prospectively evaluate the association between plasma HGF and risk of ischemic stroke within the WomenÊ's Health Initiative Observational Study, a cohort of postmenopausal women aged 50 to 79 years. RESULTS-: Baseline HGF levels were correlated positively with body mass index, systolic blood pressure, low-density lipoprotein cholesterol, insulin resistance, and inflammatory markers, such as C-reactive protein, and inversely with high-density lipoprotein cholesterol (all P<0.05). Baseline HGF levels were higher among cases than controls (geometric means, 601.8 vs 523.2 pg/mL; P=0.003). Furthermore, the risk of incident ischemic stroke was significantly greater among women in the highest vs lowest quartile of plasma HGF levels (OR, 1.46; 95% CI, 1.12-1.91; Ptrend=0.003) in a conditional logistic regression model that adjusted for body mass index. These results were only slightly attenuated after further adjustment for additional stroke risk factors (OR, 1.39; 95% CI, 1.04-1.85; Ptrend=0.023). CONCLUSIONS-: Circulating levels of HGF are associated with an increased risk of incident ischemic stroke, independent of obesity and other risk factors for cardiovascular disease, among postmenopausal women aged 50 to 79 years.

KW - Hepatocyte growth factor

KW - Ischemic stroke

KW - Women

UR - http://www.scopus.com/inward/record.url?scp=77951768843&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951768843&partnerID=8YFLogxK

U2 - 10.1161/STROKEAHA.109.567719

DO - 10.1161/STROKEAHA.109.567719

M3 - Article

C2 - 20203323

AN - SCOPUS:77951768843

VL - 41

SP - 857

EP - 862

JO - Stroke

JF - Stroke

SN - 0039-2499

IS - 5

ER -